---
title: "Ipca Laboratories Ltd (IPCALAB) — Share Price, Financials & Analysis"
symbol: "IPCALAB"
company: "Ipca Laboratories Ltd"
canonical: "https://tapetide.com/stocks/IPCALAB"
isin: "INE571A01038"
nse_symbol: "IPCALAB"
bse_code: "524494"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 49832.58
generated_at: "2026-09-13T18:56:19.818Z"
---

# Ipca Laboratories Ltd (IPCALAB)

Canonical page: https://tapetide.com/stocks/IPCALAB

## Company

- **NSE Symbol:** IPCALAB
- **BSE Code:** 524494
- **ISIN:** INE571A01038
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 1995-02-01
- **CEO:** Mr. Premchand Godha A.C. A., B. Com., CA
- **Employees:** 16778
- **Face Value:** ₹1
- **F&O Eligible:** No
- **Website:** ipca.com

## About

Ipca Laboratories is an integrated pharmaceutical company manufacturing branded and generic formulations, APIs and intermediates. Indian branded formulations are its core profit engine, complemented by formulation exports across Europe, Africa, the Americas, Asia, CIS and Australasia. The consolidated business includes Unichem Laboratories and its US, Brazil, Europe and South Africa operations.[1]

## Latest Price

- **Price:** ₹1968.5
- **Change:** -2.4 (-0.12%)
- **Open:** ₹1975.8
- **Day High:** ₹1995
- **Day Low:** ₹1958.4
- **Previous Close:** ₹1970.9
- **Volume:** 176417
- **As Of:** 2026-09-11T10:01:38+00:00

## Key Fundamentals

Observed at 2026-09-11T04:47:17.396984Z.

- **Market Cap:** ₹49832.58 Cr
- **Classification:** Midcap
- **P/E (reported):** 36.3
- **P/E (TTM):** 38.13
- **EPS (TTM):** ₹51.63
- **EPS (reported):** ₹23.14
- **Book Value:** ₹317.84
- **Price to Book:** 6.2
- **Dividend Yield:** 0.3%
- **ROE:** 12.51%
- **ROCE:** 16.38%
- **Debt to Equity:** 0.1
- **Revenue (yearly):** ₹9820.8 Cr
- **Net Income:** ₹1191.4 Cr
- **EBITDA:** ₹2153 Cr
- **52-Week High:** ₹2001.5
- **52-Week Low:** ₹1251.6
- **RSI (14):** 64.85

## Tapetide Score

- **Score:** 54 / 100
- **Score date:** 2026-09-04
- **Archetype:** Average Quality, Undemanding Price
- **What it means:** The financials sit mid-range rather than strong, and the multiple is not demanding. Nothing here stands out in either direction, so the read comes down to which single pillar you weight most and whether the next results move it off the middle.
- **Pillar profile:** Quality: Average · Valuation: Cheap · Momentum: Rising
- **Percentile:** 65.6 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 70.1 | 9% |
| growth | 26.66 | 9% |
| momentum | 62.89 | 12% |
| ownership | 48.12 | 24% |
| quality | 53.2 | 22% |
| valuation | 63.2 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company has reduced debt.

### Weaknesses

- Stock is trading at 6.19 times its book value
- Company has a low return on equity of 12.9% over last 3 years.

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -13.57% | 20.89% | 33.4% |
| ebitda margin growth | 30.65% | 8.84% | 18.68% | -6.04% |
| net income growth | 38.34% | 51.29% | 37% | 1% |
| revenue growth | 13.34% | 8.73% | 16% | 12% |
| roce | 37.52% | 26.29% | 45.99% | 14.14% |
| roe | 38.34% | 33.23% | 9.58% | -23.53% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 2034 | 2053 | 2033 | 2093 | 2355 | 2245 | 2247 | 2309 | 2556 | 2392 | 2388 | 2788 |
| Expenses | 1673 | 1722 | 1711 | 1700 | 1913 | 1782 | 1818 | 1892 | 2012 | 1859 | 1905 | 2119 |
| Operating Profit | 361 | 331 | 322 | 393 | 441 | 463 | 429 | 416 | 545 | 533 | 484 | 670 |
| OPM % | 18 | 16 | 16 | 19 | 19 | 21 | 19 | 18 | 21 | 22 | 20 | 24 |
| Other Income | -1 | 91 | -118 | 21 | 26 | 20 | -179 | 33 | -30 | 38 | 48 | 25 |
| Interest | 44 | 33 | 29 | 24 | 23 | 17 | 22 | 19 | 20 | 18 | 20 | 12 |
| Depreciation | 90 | 100 | 98 | 99 | 100 | 98 | 100 | 100 | 103 | 108 | 107 | 111 |
| Profit before tax | 225 | 289 | 77 | 290 | 345 | 368 | 128 | 331 | 392 | 446 | 404 | 572 |
| Tax % | 39 | 23 | 96 | 31 | 29 | 25 | 49 | 29 | 28 | 18 | 24 | 26 |
| Net Profit | 136 | 221 | 1 | 199 | 246 | 276 | 64 | 233 | 281 | 364 | 307 | 424 |
| EPS in Rs | 5.72 | 7.09 | 2.35 | 7.58 | 9.05 | 9.78 | 2.67 | 9.19 | 11.14 | 12.86 | 11.79 | 15.84 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 3258 | 3746 | 4619 | 5395 | 5797 | 6204 | 7662 | 8897 | 9599 | 10126 |
| Expenses | 2803 | 3051 | 3715 | 3843 | 4472 | 5272 | 6338 | 7166 | 7609 | 7894 |
| Operating Profit | 455 | 695 | 904 | 1552 | 1325 | 932 | 1324 | 1731 | 1990 | 2232 |
| OPM % | 14 | 19 | 20 | 29 | 23 | 15 | 17 | 19 | 21 | 22 |
| Other Income | 41 | 56 | 65 | 59 | 54 | 123 | 17 | -114 | 80 | 81 |
| Interest | 28 | 22 | 20 | 12 | 11 | 48 | 141 | 88 | 79 | 69 |
| Depreciation | 178 | 182 | 210 | 209 | 232 | 262 | 357 | 398 | 418 | 429 |
| Profit before tax | 291 | 546 | 739 | 1389 | 1136 | 745 | 843 | 1131 | 1573 | 1814 |
| Tax % | 18 | 19 | 18 | 17 | 20 | 34 | 37 | 30 | 24 | — |
| Net Profit | 239 | 442 | 604 | 1141 | 890 | 479 | 523 | 785 | 1184 | 1375 |
| EPS in Rs | 9.49 | 17.6 | 23.99 | 44.94 | 34.85 | 18.58 | 21.57 | 29.08 | 44.98 | 51.63 |
| Dividend Payout % | 5 | 9 | 10 | 9 | 11 | 22 | 19 | 14 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 | 25 |
| Reserves | 2430 | 2663 | 3097 | 3602 | 4676 | 5467 | 5817 | 6307 | 6923 | 8038 |
| Borrowings | 716 | 628 | 465 | 501 | 265 | 807 | 1481 | 1438 | 1363 | 809 |
| Other Liabilities | 788 | 799 | 961 | 1130 | 1099 | 1338 | 1300 | 3326 | 3432 | 3477 |
| Total Liabilities | 3960 | 4116 | 4549 | 5258 | 6066 | 7637 | 8623 | 11097 | 11744 | 12350 |
| Fixed Assets | 1983 | 1953 | 1940 | 2059 | 2072 | 2418 | 2751 | 4554 | 4267 | 4627 |
| CWIP | 95 | 73 | 66 | 133 | 235 | 306 | 140 | 343 | 622 | 773 |
| Investments | 136 | 87 | 120 | 310 | 505 | 989 | 626 | 862 | 980 | 844 |
| Other Assets | 1746 | 2003 | 2422 | 2756 | 3254 | 3924 | 5105 | 5339 | 5875 | 6106 |
| Total Assets | 3960 | 4116 | 4549 | 5258 | 6066 | 7637 | 8623 | 11097 | 11744 | 12350 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 282 | 341 | 501 | 570 | 1090 | 856 | 806 | 945 | 1321 | 1142 |
| Cash from Investing Activity | -149 | -135 | -165 | -509 | -521 | -851 | -725 | -1215 | -870 | -247 |
| Cash from Financing Activity | -159 | -130 | -183 | -137 | -306 | 427 | 507 | -553 | -283 | -754 |
| Net Cash Flow | -26 | 75 | 153 | -76 | 264 | 432 | 588 | -823 | 169 | 142 |
| Free Cash Flow | 147 | 206 | 322 | 277 | 731 | 380 | 347 | 543 | 551 | 486 |
| CFO/OP | 74 | 88 | 88 | 80 | 86 | 80 | 110 | 94 | 97 | 78 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 58 | 67 | 66 | 71 | 55 | 57 | 58 | 80 | 77 | 77 |
| Inventory Days | 290 | 286 | 316 | 294 | 337 | 337 | 276 | 350 | 336 | 353 |
| Days Payable | 130 | 137 | 154 | 135 | 140 | 101 | 83 | 110 | 111 | 122 |
| Cash Conversion Cycle | 218 | 216 | 228 | 229 | 251 | 293 | 251 | 321 | 302 | 308 |
| Working Capital Days | 74 | 80 | 88 | 88 | 103 | 102 | 71 | 111 | 101 | 109 |
| ROCE % | 9 | 10 | 16 | 19 | 31 | 20 | 11 | 13 | 15 | 17 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 46.29% | 46.29% | 46.3% | 46.3% | 46.3% | 44.72% | 44.72% | 44.72% | 44.72% | 44.72% | 44.72% | 44.72% |
| FIIs | 9.86% | 10.27% | 10.51% | 10.85% | 10.83% | 11.07% | 10.76% | 10.67% | 10.43% | 10.63% | 10.63% | 10.73% |
| DIIs | 34.73% | 33.79% | 34.05% | 33.46% | 33.91% | 35.36% | 35.74% | 35.88% | 36.45% | 37% | 37.13% | 37.05% |
| Government | 0.32% | 0% | 0.32% | 0.32% | 0.32% | 0.32% | 0.32% | 0.32% | 0.32% | 0.32% | 0.32% | 0.32% |
| Public | 7.14% | 7.12% | 7.13% | 7.27% | 6.93% | 6.88% | 6.81% | 6.82% | 6.55% | 5.88% | 5.79% | 5.76% |
| Others | 1.67% | 2.53% | 1.69% | 1.79% | 1.71% | 1.65% | 1.65% | 1.59% | 1.53% | 1.44% | 1.41% | 1.42% |
| No. of Shareholders | 95930 | 82809 | 81165 | 84753 | 82975 | 90189 | 88306 | 85582 | 82870 | 77673 | 82184 | 82060 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 13 / 5 / 1

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 1966.97 | Buy |
| EMA (10) | 1958.78 | Buy |
| SMA (20) | 1943.14 | Buy |
| EMA (20) | 1928.45 | Buy |
| SMA (50) | 1845.72 | Buy |
| EMA (50) | 1844.97 | Buy |
| SMA (100) | 1716.54 | Buy |
| EMA (100) | 1749.25 | Buy |
| SMA (200) | 1594.79 | Buy |
| EMA (200) | 1642.28 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 64.18 | Neutral |
| MACD (12,26,9) | 43.84 | Sell |
| Stochastic (14,3,3) | 67.15 | Neutral |
| ADX (14) | 32.23 | Buy |
| Williams %R (14) | -35.26 | Neutral |
| ATR (14) | 49.8 | Neutral |
| ROC (12) | 0.82 | Buy |
| Stoch RSI (14) | 8.3 | Buy |
| UO (7,14,28) | 50.29 | Neutral |

## Analyst Ratings

| Recommendation | Analysts | Share |
| --- | --- | --- |
| Buy | 12 | 75% |
| Hold | 2 | 12.5% |
| Sell | 2 | 12.5% |

Based on 16 analyst ratings, observed at 2026-09-11T04:47:16.559194+00:00.

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-08-17 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=caea77f2-90b4-4817-8d4f-d660472e57f4.pdf) |
| 2026-08-14 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=80cb5f09-0f6f-42b8-95e3-ff8d2752dc1c.pdf) |
| 2026-08-14 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c9919170-111a-42be-9038-b93f70a70071.pdf) |
| 2026-08-14 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=acb02de9-2b67-4e42-93b5-ff4957fb2a43.pdf) |
| 2026-08-13 | [Board Meeting Outcome for Standalone And Consolidated Unaudited Financial Results For Q1FY27](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=32befe2b-81de-488a-bd88-af0d20c4d183.pdf) |
| 2026-08-13 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a7595f13-aa5c-425e-9969-74d005a2cd6a.pdf) |
| 2026-08-06 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b16a6eec-79ea-4398-8560-29294d64a012.pdf) |
| 2026-07-28 | [Board Meeting Intimation for Standalone And Consolidated Financial Results For 1St Quarter Ended 30Th June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8daffe31-668d-42c7-9af6-54241565be42.pdf) |
| 2026-07-17 | [Intimation Of Web Link To Non-Email Cases](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=20236742-7643-451f-a8b1-56030c98c5d1.pdf) |
| 2026-07-15 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=abade71c-a0ad-4b15-a0f2-05cf46b731f3.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-13 | [Standalone And Consolidated Unaudited Financial Results For Q1FY27](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=150ef46a-e074-4fe1-af51-e0025561141e.pdf) |
| 2026-05-29 | [Standalone And Consolidated Results Q4FY26](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=43303bfb-a916-4171-822e-f01e12089df4.pdf) |
| 2026-02-13 | [Standalone And Consolidated Financial Results For Q3FY26](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ae922d64-58fd-4cfd-9d5e-e423e8625b3e.pdf) |
| 2025-11-13 | [Standalone And Consolidated Q2-H1 FY26 Results And Press Release](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1275d98e-d06a-4bd3-bcec-b7056ed6a3e8.pdf) |
| 2025-08-11 | [Financial Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1e238847-43e3-47a1-967a-5e27deeeae66.pdf) |
| 2025-05-29 | [Standalone And Consolidated Audited Financial Results For Q4FY25](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0753d5e9-4024-4b3d-824b-83f6e19e8a00.pdf) |
| 2025-02-13 | [Standalone And Consolidated Q3FY25 Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2cd03d90-1695-4403-881f-0e914c860b70.pdf) |
| 2024-11-14 | [Unaudited Standalone And Consolidated Financial Results For Q2H1FY25](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9311a708-2d79-4854-abb2-b6517f810dec.pdf) |
| 2024-08-13 | [Standalone And Consolidated Unaudited Financial Results For Q1FY25](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9f42819f-f964-4d9f-9c9d-3cce4692a7ee.pdf) |
| 2024-05-29 | [Standalone And Consolidated Results For Q4 And FY24](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c3dc8212-f9c6-4045-938e-eaadc7c38947.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/aee9ffc2-d048-49b3-8d0e-02f1109063f3.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1687beaa-a6bd-4fca-9d09-f47f7c7d7d08.pdf) |
| Nov 2024 | [Concall - Nov 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1687beaa-a6bd-4fca-9d09-f47f7c7d7d08.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=55d4dd8a-d603-41db-8a99-dc8efefed623.pdf) |
| Nov 2023 | [Concall - Nov 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/55d4dd8a-d603-41db-8a99-dc8efefed623.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/48e4309a-f142-4094-9112-18b2eb2ad896.pdf) |
| Nov 2021 | [Concall - Nov 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/10e9e7b0-efec-416f-8d06-dd97ca08a019.pdf) |
| May 2022 | [Concall - May 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/383a21a7-80fc-48a9-b7a4-7ce5054993db.pdf) |
| Jun 2026 | [Concall - Jun 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/6ce825c6-0b7d-4c43-a740-7d17dd43ab03.pdf) |
| Jun 2025 | [Concall - Jun 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/e67a7e56-1092-4e88-ad57-8f5cdc04a427.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 8 Apr - Regulation 74(5) compliance certificate for quarter ended March 31, 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 8 Apr - Regulation 74(5) compliance certificate for quarter ended March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4240bf3a-7610-48d1-83c0-76b815eced92.pdf) |
| 4 May - Board to meet on 29 May 2026 for Q4 FY26 audited results and dividend recommendation. | [Board Meeting Intimation for Standalone And Consolidated Financial Results For 4Th Quarter And Financial Year Ended 31St March 2026 And Dividend 4 May - Board to meet on 29 May 2026 for Q4 FY26 audited results and dividend recommendation.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/3e4505f3-f2bd-4831-92ab-9bd9dedcc60e.pdf) |
| 4 May - Board to meet on 29 May 2026 for Q4 FY26 audited results and dividend recommendation. | [Board Meeting Intimation for Standalone And Consolidated Financial Results For 4Th Quarter And Financial Year Ended 31St March 2026 And Dividend 4 May - Board to meet on 29 May 2026 for Q4 FY26 audited results and dividend recommendation.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/3e4505f3-f2bd-4831-92ab-9bd9dedcc60e.pdf) |
| 2 Apr - Newspaper Notice issued by the Company regarding transfer of physical shares. | [Announcement under Regulation 30 (LODR)-Newspaper Publication 2 Apr - Newspaper Notice issued by the Company regarding transfer of physical shares.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/eb6af2df-3c46-4e45-9564-eeccfc8434d5.pdf) |
| 18 Feb - Q3 FY26 earnings call transcript (Feb 16, 2026): Q3 revenue INR2,245 crore; 9M INR7,258 crore; margins improved. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 18 Feb - Q3 FY26 earnings call transcript (Feb 16, 2026): Q3 revenue INR2,245 crore; 9M INR7,258 crore; margins improved.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d838d359-2908-4f35-bcc0-375d5a653775.pdf) |
| 16 Mar - Trading window closed from 1 April 2026 until 48 hours after audited FY2026 results declaration. | [Closure of Trading Window 16 Mar - Trading window closed from 1 April 2026 until 48 hours after audited FY2026 results declaration.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/97d7db92-938d-4996-b02a-9c249ec43497.pdf) |
| 16 Feb - Posted audio link of Q3 FY26 earnings call held 16 Feb 2026. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 16 Feb - Posted audio link of Q3 FY26 earnings call held 16 Feb 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b667e828-97d4-4e43-b45f-949ffc9dc34e.pdf) |
| 13 Feb - Q3 & 9M FY26 results: consolidated revenue ₹2,412.69cr, net profit ₹326.27cr; acquired Unichem Ireland; €19.55m EU fine settled. | [Board Meeting Outcome for Standalone And Consolidated Financial Results For Q3FY26 13 Feb - Q3 & 9M FY26 results: consolidated revenue ₹2,412.69cr, net profit ₹326.27cr; acquired Unichem Ireland; €19.55m EU fine settled.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c3548aa7-38b8-4887-883d-80ac9fe1e3ea.pdf) |
| — | [Announcement under Regulation 30 (LODR)-Newspaper Publication 16 Feb](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ab2c9830-187b-4dee-9c64-98cc87405714.pdf) |
| — | [Standalone And Consolidated Financial Results For Q3FY26 13 Feb](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ae922d64-58fd-4cfd-9d5e-e423e8625b3e.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2026 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8a8d1352-52ce-454e-9c43-7ef525d02f29.pdf) |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/01671e9d-d23a-4084-aa03-b5f31194b2a0.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/84559e89-666a-45cc-9f48-3e4f686389f8.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/bf37f222-4822-4055-a492-06079ecbd29a.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/524494/73704524494.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/524494/69277524494.pdf) |
| from bse | [Annual Report 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/524494/5244940320.pdf) |
| from bse | [Annual Report 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/524494/5244940319.pdf) |
| from bse | [Annual Report 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/524494/5244940318.pdf) |
| from bse | [Annual Report 2017 from bse](https://www.bseindia.com/bseplus/AnnualReport/524494/5244940317.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2025-06-02 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e67a7e56-1092-4e88-ad57-8f5cdc04a427.pdf) |
| 2023-08-14 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=60441042-cc6c-46fa-9e41-5da525f570f7.pdf) |
| 2023-02-20 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7e12bd5a-f25c-44dc-9923-09ebd61ade71.pdf) |
| 2022-11-16 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=48e4309a-f142-4094-9112-18b2eb2ad896.pdf) |
| 2022-08-12 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5ea647f9-aa8e-4bd7-bedf-73921ee63cca.pdf) |
| 2022-05-27 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=383a21a7-80fc-48a9-b7a4-7ce5054993db.pdf) |
| 2022-02-17 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7be858b8-d194-41e3-b26a-b1c3ce747224.pdf) |
| 2021-11-18 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=10e9e7b0-efec-416f-8d06-dd97ca08a019.pdf) |
| 2021-08-09 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=807badfc-0511-41ca-a045-156a6f8dd0bb.pdf) |
| 2021-06-01 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=161ed311-0442-4122-8ee8-fab75aff95e7.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:56:19.818Z.